Visara appoints ophthalmology leaders to advance VIS-101 drug program
Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program| (NASDAQ: AURA) | Delayed: 5.60 -0.1 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.70 | 52 Week High | $ | |||
| Open | $5.57 | 52 Week Low | $ | |||
| Day High | $5.76 | P/E | N/A | |||
| Day Low | $5.44 | EPS | $ | |||
| Volume | 188,952 | |||||
| (NASDAQ: FDMT) | Delayed: 8.48 -0.16 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.64 | 52 Week High | $ | |||
| Open | $8.40 | 52 Week Low | $ | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.19 | EPS | $ | |||
| Volume | 516,915 | |||||
| (NASDAQ: NBP) | Delayed: 3.50 -0.14 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.64 | 52 Week High | $6.95 | |||
| Open | $3.56 | 52 Week Low | $6.95 | |||
| Day High | $3.71 | P/E | 1.64 | |||
| Day Low | $3.41 | EPS | $2.14 | |||
| Volume | 1,578,534 | |||||

